SCHEMBL17032229

SCHEMBL17032229

CCC[C@@H](O)[C@@H](CC)N=[N+]=[N-]

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SGPL1 O95470 8/20 0.45
▸ LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16381727 0.80 SGPL1 (0.36) SGPL1LMNA
SCHEMBL16740884 0.76 SGPL1 (0.39) SGPL1
SCHEMBL15868232 0.75 SGPL1 (0.32) SGPL1
SCHEMBL21524933 0.75 — —
SCHEMBL21524935 0.75 — —
SCHEMBL17316269 0.72 — —
SCHEMBL16369037 0.71 SGPL1 (0.36) SGPL1LMNA
SCHEMBL15176857 0.71 SGPL1 (0.36) SGPL1LMNA
SCHEMBL18719988 0.70 SGPL1 (0.34) SGPL1
SCHEMBL15738811 0.69 CHRM1 (0.40) SGPL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015124941-A1 PYRAZOLO[1,5-A]PYRIMIDINE-5,7-DIAMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2015-08-27 — — WO disclosed
Send feedback